Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:22 PM
Ignite Modification Date:
2025-12-26 @ 5:22 PM
NCT ID:
NCT07115706
Eligibility Criteria:
Inclusion Criteria:
* subjects aged 19 years or older who have been diagnosed with erosive reflux disease (ERD)
* subjects who have voluntarily decided to participate in this observational study and have provided written informed consent after receiving the study information and consent form
Exclusion Criteria:
* Subjects who fall under the contraindications listed in the precautions for use section of the approved labeling for Fexuclu tablets:
1. Subjects with hypersensitivity or a history of hypersensitivity to the investigational drug or any of its components
2. Subjects currently taking medications containing atazanavir, nelfinavir, or rilpivirine
3. Pregnant women, women who may be pregnant, or breastfeeding women
4. Subjects with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
* Subjects deemed inappropriate for participation in the study at the investigator's discretion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT07115706
Study Brief:
Protocol Section:
NCT07115706